Biotech | May 19, 2022
Piramal Pharma Solutions new API plant in Canada goes online
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
This new fund is amongst the largest for the sector in India
Multiples is the first private equity (PE) investor in the company
Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.
The company also raised Rs 270 crore investment from Temasek in 2019
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
The plant is expected to start commercial operations from Q4FY24
The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital
Subscribe To Our Newsletter & Stay Updated
